ArticleInternational journal of molecular sciences2025

KRAS-SOS-1 Inhibition as New Pharmacological Target to Counteract Anaplastic Thyroid Carcinoma (ATC).

Deborah Mannino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.